The UT MD Anderson Cancer Center Community Clinical Oncology Program Research Bas
UT MD 安德森癌症中心社区临床肿瘤学项目研究基地
基本信息
- 批准号:8528341
- 负责人:
- 金额:$ 188.53万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:1996
- 资助国家:美国
- 起止时间:1996-09-30 至 2015-07-31
- 项目状态:已结题
- 来源:
- 关键词:Acupuncture procedureAcuteAffectAreaBasic ScienceBehaviorBeliefBiological FactorsCancer CenterCancer ControlCancer Control ResearchCancer PatientCaringChronicClinicalClinical InvestigatorClinical ResearchClinical TrialsClinical Trials DesignCollectionCommunicationCommunitiesCommunity Clinical Oncology ProgramConduct Clinical TrialsControlled StudyCounselingDataDivision of Cancer PreventionExerciseFacultyFamilyGoalsHealthInstructionInternal MedicineInterventionKnowledgeLate EffectsLeadershipMalignant NeoplasmsMedicineMentorshipMind-Body InterventionNCI Center for Cancer ResearchOncologistOutcomePatient CarePatient Outcomes AssessmentsPatientsPersonal SatisfactionPopulationPopulation SciencesPreventionProcessProspective StudiesQuality of lifeResearchResearch PersonnelResourcesRiskScienceScientistSiteSocial MarketingStructureToxic effectUniversity of Texas M D Anderson Cancer CenterWomen PhysiciansWorkactive methodbasecancer recurrencecancer therapycommunity settingdesigndisorder preventionimprovedinnovationnovel strategiespre-clinicalprogramspsychologicrapid growthresearch studyresponsesocialsurvivorship
项目摘要
DESCRIPTION (provided by applicant): The MD Anderson Cancer Center CCOP Research Base (RB) is a venue for transdisciplinary cancer control research within MDACC, and connecting this research to community oncologists and other academic centers, in order to improve patient care. Hypothesis: our cancer center RB, using its full breadth and scope of clinicians, basic and population science researchers, community partners, and robust expertise in all aspects of clinical investigation, while leveraging the resources available at MDACC, can create and disseminate critical new knowledge in cancer control through the process of team science and clinical research innovation. Specific aims: Aim 1. To conduct interventional clinical trials and other prospective studies in the realm of cancer control to enhance the health and well-being of patients affected by cancer or at risk for cancer recurrence. (1a) To develop and conduct clinical trials and other prospective studies in integrative health in order to optimize health, quality of life, and clinical outcomes of patients and families across the cancer continuum; (1b) To develop and conduct interventional trials and prospective studies directed at understanding and reducing the burden of cancer treatment toxicity; (1c) To incorporate novel approaches to the design, conduct, and analysis of clinical trials. Aim 2. To promote cancer control science among our community oncology sites, academic cancer center faculty and fellows, and the lay public. (2a) To enhance interactions between preclinical and clinical investigators to better inform the design of clinical trials and enhance the collection and interpretation of pilot data and correlative science; (2b) To develop cancer control studies relevant to all stakeholders and involving the collection of patient-reported outcome data and data related to observed patient behaviors; (2c) To use multiple modes of communication to disseminate the healthy goals and step-by-step processes involved in cancer control research; (2d) To use mentorship and institutional leadership to promote the inclusion of young investigators and women physicians and scientists in the CCOP research base; (2e) To develop and share best practices for the inclusion of underrepresented populations in our clinical research studies and on our research teams.
RELEVANCE (See instructions): The MD Anderson Cancer Center CCOP Research Base delivers innovative studies directly to patients in the community setting, in order to improve patient care and facilitate the discovery and dissemination of new information that impacts the field of cancer medicine.
描述(由申请人提供):MD安德森癌症中心CCOP研究基地(RB)是MDACC内进行跨学科癌症控制研究的场所,并将该研究与社区肿瘤学家和其他学术中心联系起来,以改善患者护理。假设:我们的癌症中心RB,利用其临床医生,基础和人口科学研究人员,社区合作伙伴的全面广度和范围,以及临床研究各个方面的强大专业知识,同时利用MDACC的可用资源,可以通过团队科学和临床研究创新的过程,创造和传播癌症控制的关键新知识。具体目标:目标1。在癌症控制领域进行干预性临床试验和其他前瞻性研究,以改善受癌症影响或有癌症复发风险的患者的健康和福祉。(1a)开发和进行综合健康方面的临床试验和其他前瞻性研究,以优化癌症患者和家庭的健康,生活质量和临床结果;(1b)开发和进行干预性试验和前瞻性研究,旨在了解和减少癌症治疗毒性的负担;(1c)将新方法纳入临床试验的设计、实施和分析。目标二。在我们的社区肿瘤学站点,学术癌症中心的教职员工和研究员以及普通公众中推广癌症控制科学。(2a)加强临床前和临床研究人员之间的互动,以便更好地为临床试验的设计提供信息,并加强对试点数据和相关科学的收集和解释;(2b)开展与所有利益攸关方相关的癌症控制研究,并收集患者报告的结果数据和与观察到的患者行为相关的数据;(2c)利用多种交流方式宣传癌症控制研究所涉的健康目标和逐步进程;(2d)利用指导和机构领导,促进将青年调查员、女医生和女科学家纳入民间社会调查委员会的研究基地;(2 e)制定和分享最佳做法,将代表性不足的人群纳入我们的临床研究和研究团队。
相关性(参见说明):MD安德森癌症中心CCOP研究基地直接向社区环境中的患者提供创新研究,以改善患者护理并促进影响癌症医学领域的新信息的发现和传播。
项目成果
期刊论文数量(40)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
The relationship of chemotherapy-induced nausea to the frequency of pericardium 6 digital acupressure.
化疗引起的恶心与心包6指压频率的关系。
- DOI:10.1188/10.onf.e419-e425
- 发表时间:2010
- 期刊:
- 影响因子:1.9
- 作者:Lee,Jiyeon;Dibble,Suzanne;Dodd,Marylin;Abrams,Donald;Burns,Beverly
- 通讯作者:Burns,Beverly
Association between Tumor Characteristics and Bone Mineral Density in Postmenopausal Breast Cancer Patients.
绝经后乳腺癌患者肿瘤特征与骨矿物质密度之间的关联。
- DOI:10.1111/tbj.12141
- 发表时间:2013
- 期刊:
- 影响因子:0
- 作者:Bayraktar,Soley;Avery,Tiffany;Altundag,Kadri;Broglio,Kristine;Arun,BanuK
- 通讯作者:Arun,BanuK
Oral alpha-lipoic acid to prevent chemotherapy-induced peripheral neuropathy: a randomized, double-blind, placebo-controlled trial.
- DOI:10.1007/s00520-013-2075-1
- 发表时间:2014-05
- 期刊:
- 影响因子:0
- 作者:Guo Y;Jones D;Palmer JL;Forman A;Dakhil SR;Velasco MR;Weiss M;Gilman P;Mills GM;Noga SJ;Eng C;Overman MJ;Fisch MJ
- 通讯作者:Fisch MJ
Lung cancer chemoprevention: an integrated approach.
肺癌化学预防:一种综合方法。
- DOI:
- 发表时间:2001
- 期刊:
- 影响因子:0
- 作者:Lippman,SM;Spitz,MR
- 通讯作者:Spitz,MR
Acupressure for chemotherapy-induced nausea and vomiting: a randomized clinical trial.
穴位按摩治疗化疗引起的恶心和呕吐:一项随机临床试验。
- DOI:10.1188/07.onf.xxx-xxx
- 发表时间:2007
- 期刊:
- 影响因子:1.9
- 作者:Dibble,SuzanneL;Luce,Judy;Cooper,BruceA;Israel,Jill;Cohen,Misha;Nussey,Brenda;Rugo,Hope
- 通讯作者:Rugo,Hope
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Robert Wolff其他文献
Robert Wolff的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Robert Wolff', 18)}}的其他基金
相似海外基金
Acute senescence: a novel host defence counteracting typhoidal Salmonella
急性衰老:对抗伤寒沙门氏菌的新型宿主防御
- 批准号:
MR/X02329X/1 - 财政年份:2024
- 资助金额:
$ 188.53万 - 项目类别:
Fellowship
Transcriptional assessment of haematopoietic differentiation to risk-stratify acute lymphoblastic leukaemia
造血分化的转录评估对急性淋巴细胞白血病的风险分层
- 批准号:
MR/Y009568/1 - 财政年份:2024
- 资助金额:
$ 188.53万 - 项目类别:
Fellowship
Combining two unique AI platforms for the discovery of novel genetic therapeutic targets & preclinical validation of synthetic biomolecules to treat Acute myeloid leukaemia (AML).
结合两个独特的人工智能平台来发现新的基因治疗靶点
- 批准号:
10090332 - 财政年份:2024
- 资助金额:
$ 188.53万 - 项目类别:
Collaborative R&D
Cellular Neuroinflammation in Acute Brain Injury
急性脑损伤中的细胞神经炎症
- 批准号:
MR/X021882/1 - 财政年份:2024
- 资助金额:
$ 188.53万 - 项目类别:
Research Grant
STTR Phase I: Non-invasive focused ultrasound treatment to modulate the immune system for acute and chronic kidney rejection
STTR 第一期:非侵入性聚焦超声治疗调节免疫系统以治疗急性和慢性肾排斥
- 批准号:
2312694 - 财政年份:2024
- 资助金额:
$ 188.53万 - 项目类别:
Standard Grant
Combining Mechanistic Modelling with Machine Learning for Diagnosis of Acute Respiratory Distress Syndrome
机械建模与机器学习相结合诊断急性呼吸窘迫综合征
- 批准号:
EP/Y003527/1 - 财政年份:2024
- 资助金额:
$ 188.53万 - 项目类别:
Research Grant
FITEAML: Functional Interrogation of Transposable Elements in Acute Myeloid Leukaemia
FITEAML:急性髓系白血病转座元件的功能研究
- 批准号:
EP/Y030338/1 - 财政年份:2024
- 资助金额:
$ 188.53万 - 项目类别:
Research Grant
KAT2A PROTACs targetting the differentiation of blasts and leukemic stem cells for the treatment of Acute Myeloid Leukaemia
KAT2A PROTAC 靶向原始细胞和白血病干细胞的分化,用于治疗急性髓系白血病
- 批准号:
MR/X029557/1 - 财政年份:2024
- 资助金额:
$ 188.53万 - 项目类别:
Research Grant
ロボット支援肝切除術は真に低侵襲なのか?acute phaseに着目して
机器人辅助肝切除术真的是微创吗?
- 批准号:
24K19395 - 财政年份:2024
- 资助金额:
$ 188.53万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Collaborative Research: Changes and Impact of Right Ventricle Viscoelasticity Under Acute Stress and Chronic Pulmonary Hypertension
合作研究:急性应激和慢性肺动脉高压下右心室粘弹性的变化和影响
- 批准号:
2244994 - 财政年份:2023
- 资助金额:
$ 188.53万 - 项目类别:
Standard Grant